Antibiotic Selection Pressure Determination through Sequence-Based Metagenomics

Antimicrob Agents Chemother. 2015 Dec;59(12):7335-45. doi: 10.1128/AAC.01504-15. Epub 2015 Sep 14.

Abstract

The human gut forms a dynamic reservoir of antibiotic resistance genes (ARGs). Treatment with antimicrobial agents has a significant impact on the intestinal resistome and leads to enhanced horizontal transfer and selection of resistance. We have monitored the development of intestinal ARGs over a 6-day course of ciprofloxacin (Cp) treatment in two healthy individuals by using sequenced-based metagenomics and different ARG quantification methods. Fixed- and random-effect models were applied to determine the change in ARG abundance per defined daily dose of Cp as an expression of the respective selection pressure. Among various shifts in the composition of the intestinal resistome, we found in one individual a strong positive selection for class D beta-lactamases which were partly located on a mobile genetic element. Furthermore, a trend to a negative selection has been observed with class A beta-lactamases (-2.66 hits per million sample reads/defined daily dose; P = 0.06). By 4 weeks after the end of treatment, the composition of ARGs returned toward their initial state but to a different degree in both subjects. We present here a novel analysis algorithm for the determination of antibiotic selection pressure which can be applied in clinical settings to compare therapeutic regimens regarding their effect on the intestinal resistome. This information is of critical importance for clinicians to choose antimicrobial agents with a low selective force on their patients' intestinal ARGs, likely resulting in a diminished spread of resistance and a reduced burden of hospital-acquired infections with multidrug-resistant pathogens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Algorithms
  • Anti-Bacterial Agents / pharmacology*
  • Biodiversity
  • Ciprofloxacin / pharmacology
  • Drug Resistance, Microbial / drug effects*
  • Drug Resistance, Microbial / genetics*
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / genetics
  • Humans
  • Male
  • Metagenomics / methods*
  • Real-Time Polymerase Chain Reaction / methods
  • Selection, Genetic / drug effects
  • beta-Lactamases / genetics

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin
  • beta-Lactamases